CVS to Separate Drugstores from Health Insurance: What Patients and Shoppers Need to Know

Source: Shutterstock

If you regularly pick up prescriptions at CVS, you might be wondering whether your neighborhood drugstore is about to change. The healthcare giant has announced one of the biggest shakeups in its history, raising questions about everything from medication prices to store locations. But the implications extend beyond the pharmacy counter. The decision could reshape how millions of Americans access medications, use their insurance, and choose where to fill prescriptions. Here’s what shoppers should know before the changes begin.

CVS Has Become Much More Than A Drugstore

Source: Unsplash

Most people recognize CVS as the place to buy prescriptions, toothpaste, or cold medicine. Behind that familiar storefront, however, sits a much larger healthcare operation. CVS owns health insurer Aetna, pharmacy benefit manager Caremark, and several healthcare service businesses. Its expansion included acquiring Caremark in 2007 and Aetna in 2018. The goal was to bring different parts of healthcare under one corporate roof. Now, CVS is reconsidering how those businesses should fit together.

Running Everything Together Has Become Complicated

Source: Wikimedia Commons

The original strategy promised convenience, but owning multiple healthcare businesses also creates competing responsibilities. Aetna manages insurance coverage, Caremark helps administer prescription benefits, and CVS pharmacies dispense medications. Meanwhile, drugstores face competition from online retailers and prescription delivery services, while insurers are dealing with higher medical expenses. Lawmakers have also questioned whether companies controlling several parts of the prescription process have too much influence over competition and costs. Those pressures help explain why CVS is changing direction.

CVS Plans To Become Two Separate Companies

Source: Shutterstock

On November 4, CVS announced plans to divide into two independently traded companies, with the separation expected to finish during the first half of 2028. One business, called CVS Pharmacy, will operate approximately 9,000 retail pharmacies, mail-order services and MinuteClinic locations. The other will retain the CVS Health name temporarily and include Aetna, Caremark, CVS Specialty, Oak Street Health and Signify Health. The companies will have separate leadership, with David Joyner overseeing the healthcare business and Prem Shah leading CVS Pharmacy.

Your Local CVS Isn’t Suddenly Disappearing

Source: Pexels

For everyday shoppers, the immediate news is reassuring: CVS hasn’t announced store closures as part of the separation. Customers can continue using their local pharmacies, and the restructuring itself doesn’t require anyone to transfer prescriptions. However, the longer-term picture is less certain. Douglas Hoey of the National Community Pharmacists Association believes a standalone CVS Pharmacy could examine underperforming locations more closely, potentially leading to additional closures. That’s an industry expert’s prediction, not an announced company plan.

Prescription Prices Won’t Automatically Drop

Source: Shutterstock

A corporate breakup might sound like an opportunity for cheaper medications, but patients shouldn’t expect their copays to fall overnight. Prescription costs depend on insurance coverage, pharmacy networks, negotiated prices, and benefit rules. Separating the retail stores from Caremark doesn’t automatically rewrite those arrangements. The potential benefit comes later, if the two businesses negotiate differently or competition improves. For now, there’s no announced across-the-board reduction in what CVS customers pay for prescriptions.

Aetna Members Should Watch Their Pharmacy Benefits

Source: Wikimedia Commons

The distinction between the two companies could matter particularly to people insured through Aetna or whose prescriptions are managed by Caremark. Those businesses will remain together, even though CVS drugstores will become independent. Caremark could still negotiate arrangements with CVS Pharmacy, including preferred copays or longer prescription fills. Whether patients gain more choices will depend on future contracts and pharmacy-network rules. Simply changing corporate ownership doesn’t necessarily change where an insurance plan encourages someone to fill a prescription.

Some Expensive Medications Will Stay Under CVS Health

Source: Wikimedia Commons

There’s an important exception to the drugstore separation. CVS Specialty, which handles complex and often costly medications, will remain alongside Aetna and Caremark rather than move into CVS Pharmacy. Specialty treatments can involve conditions such as cancer, multiple sclerosis and rheumatoid arthritis. That means some of the existing relationships between insurance coverage, prescription management and medication dispensing will remain intact. Patients using specialty medications shouldn’t assume the breakup will automatically expand their pharmacy options.

Independent Pharmacies Could Gain New Opportunities

Source: Shutterstock

Smaller pharmacies are watching the decision closely. Hoey argues that separating CVS’s stores from Caremark could improve competition because the pharmacy benefit manager would no longer own the retail chain. But the outcome depends on how reimbursement rates and pharmacy networks are negotiated. CVS Pharmacy will still have enormous bargaining power through its thousands of locations, while independent operators will need workable contracts to compete. More corporate separation could create opportunities, but fairer payments and lower consumer prices aren’t guaranteed.

The Real Test Comes After The Split

Source: Unsplash

The separation isn’t expected to be completed until 2028, leaving time for CVS to explain how the two businesses will work together. Patients should pay particular attention to future notices about pharmacy networks, prescription coverage and local store operations rather than assume those arrangements are changing immediately. The biggest unanswered question is whether this restructuring will make getting medication easier and more affordable. That will become clearer through the prices people pay, the pharmacies they can use and the service they receive long after the corporate split is complete.